Abstract
Glucose homeostasis is impaired in patients with non-insulin dependent diabetes mellitus (NIDDM) and this defect is due in part, to defects in glucose transport in skeletal muscle. Intense interest is now focused on whether reduced insulin-mediated glucose transport in muscle from NIDDM patients results from alterations in the insulin signal transduction pathway or from alterations in traffic and/or translocation of GLUT4 to the plasma membrane. Recently, potential targets for impaired traffic/translocation of GLUT4 have been reported to include defective phosphorylation of IRS-1 and reduced PI-3 kinase activity. In addition to insulin signaling defects, impaired glucose transport may result from a defect(s) in the activation or functional capacity of GLUT4. Because GLUT4 is dysregulated in skeletal muscle from NIDDM patients, it is an attractive target for gene therapy. Overexpression of GLUT4 in muscle results in increased glucose uptake and metabolism, and protects against the development of insulin resistance in transgenic mice. Genetic ablation of GLUT4 results in impaired insulin tolerance and defects in glucose metabolism in skeletal muscle. Because impaired muscle glucose transport leads to reduced whole body glucose uptake and hyperglycemia, understanding the molecular regulation of glucose transport in skeletal muscle is necessary to develop effective strategies to prevent or reduce the incidence of NIDDM.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alessi D. R., S. R. James, C. P. Downes, A. B. Holmes, P. R. J. Gaffney, C. B. Reese, and P. Cohen. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7: 261–269, 1997.
Andréasson, K., D. Galuska, A. Thörne, T. Sonnenfeld, and H. Wallberg-Henriksson. Decreased insulin-stimulated 3-O-methylglucose transport in in vitro incubated muscle strips from type II diabetic subjects. Acta Physiol. Scand. 142: 255–260, 1991.
Björnholm, M., Y. Kawano, M. Lehtihet, and J. R. Zierath. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524–527, 1977.
Borkman, M., L. H. Storlien, D. A. Pan, A. B. Jenkins, D. J. Chisholm, and L. V. Campbell. The relationship between insulin sensitivity and the fatty acid composition of phospholipids of skeletal muscle. N. Engl. J. Med. 328: 238–244, 1993.
Brozinick, J.T., S.C. McCoid, T.H. Reynolds, C.M. Wilson, R.W Stevenson, S.W. Cushman, and E.M. Gibbs. Regulation of cell surface GLUT4 in skeletal muscle of transgenic mice. Biochem. J. 321: 75–81, 1997.
Burgering, B. M. T. and P. J. Coffer. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599–602, 1995.
Cartee, G. D., A. G. Douen, T. Ramlal, A. Klip, and J. O. Holloszy. Stimulation of glucose transport in skeletal muscle by hypoxia. J. Appl. Physiol. 70: 1593–1600, 1991.
Charron, M. J., F. C. Brosius, S. L. Alper, H. F. Lodish. A glucose transport protein expressed predominately in insulin-sensitive tissues. Proc. Natl. Acad. Sci. USA 86: 2535–2539, 1989.
Covera, S., S. Jaspers, and M. Pasceri. Acute inhibition of insulin-stimulated glucose transport by the phos-phatase inhibitor, okadaic acid J. Biol. Chem. 266: 9271–9275, 1991.
DeFronzo, R. A., R. C. Bonadonna, and E. Ferrannini. Pathogenesis of NIDDM A balanced overview. Diabetes Care 15: 318–368, 1992.
Didichenko, S. A., B. Tilton, B. A. Hemmings, K. Ballmer-Hofer, and M. Thelen. Constitutive activation of protein kinase B and phosphorylation of p47phox by a membrane-targeted phosphoinositide 3-kinase. Curr. Biol. 6: 1271–1278, 1996.
Dohm, G. L., E. B. Tapscott, W. J. Pories, D. J. Dabbs, E. G. Flickinger, D. Meelheim, T. Fushiki, S. M. Atkinson, C. W. Elton, and J. F. Caro. An in vitro human skeletal muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 82: 486–494, 1988.
Douen, A. G., T. Ramlal, S. A. Rastogi, P. J. Bilan, G. D. Cartee, M. Vranic, J. O. Holloszy, and A. Klip. Exercise induces recruitment of the “insulin responsive” glucose transporter. Evidence for distinct intracellular insulin-and exercise-recruitable transporter pools in skeletal muscle. J. Biol. Chem. 265: 13427–13430, 1990.
Folli, F., M. J. A. Saad, Jr. M. Backer, and C. R. Kahn. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J. Clin. Invest. 92: 1787–1794, 1993.
Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF activated phosphatidylinositol 3-kinase. Cell 81: 727–736, 1995.
Galuska, D., L. A. Nolte, J. R. Zierath, and H. Wallberg-Henriksson. Effect of metformin on insulin-stimulated glucose transport in isolated muscle obtained from patients with NIDDM. Diabetologia 37: 826–832, 1994.
Gibbs, E. M., J. L. Stock, S. C. McCoid, H. A. Stukenbrok, J. E. Pessin, R. W. Stevenson, A. J. Milici AJ, and J. D. Ncneish. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J. Clin. Invest. 95: 1512–1518, 1995.
Goodyear, L. J., F. Giorgino, L. A. Sherman, J. Carey, R. J. Smith, and G. L. Dohm. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95: 2195–2204, 1995.
Handberg, A., A. Vaag, P. Damsbo, H. Beck-Nielsen, and J. Vinten. Expression of insulin-regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33: 625–627, 1990.
Hansen, P.A., E.A. Gulve, B.A. Marshall, J. Gao, J.E. Pessin, J.O. Holloszy, M. Mueckler. Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing GLUT4 glucose transporter. J. Biol. Chem. 270: 1679-1684.
Heydrick, S. J., D. Jullien, N. Gautier, J. F. Tanti, S. Giorgetti, E. Van Obberghen, and Y. Marchand-Brustel. Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J. Clin. Invest. 91: 1358–1366, 1993.
Hirshman, M. F., H. Wallberg-Henriksson, L. J. Wardzala, E. D. Horton, and E. S. Horton. Acute exercise increases the number of plasma membrane glucose transporters in rat skeletal muscle. FEBS Lett. 238: 235–239, 1990.
Ikemoto, S., K.S. Thompson, M. Takahashi, H. Itakura, M.D. Lane, and O. Ezaki. High fat diet-induced hyperglycemia: Prevention by low level expression of glucose transporter (GLUT4) minigene in transgenic mice. Proc. Natl. Acad. Sci USA 92: 3096–3099, 1995.
James, D. E. M., M. Strube, and M. M. Mueckler. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature (Lond.) 338: 83–87, 1989.
Jullien D., J. F. Tanti, S. J. Heydrick, N. Gautier, T. Grémeaux, E. van Obberghen, and Y. Le Marchand Brustel. Differential effects of oakdaic acid on insulin stimulated glucose and amino acid uptake and phosphatidylinositol 3-kinase activity. J. Biol. Chem. 268: 15246–15251, 1993.
Kahn, B. B., G. I. Schulman, R. A. DeFronzo, S. W. Cushman, and L. Rossetti. Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J. Clin. Invest. 87: 561–570 1991.
Kahn, B.B., and O. Pedersen. Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity. Endocrinology 132: 13–22, 1993.
Katz, E. B., A. E. Stenbit, K. Hatton, R. DePinho, and M. J. Charron. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature (Lond.) 377: 151–155, 1995.
Kelley, D. E., M. A. Mintun, S. C. Watkins, J. A. Simoneau, F. Jadali, A. Fredrickson, J. Beattie, and R. Thériault. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J. Clin. Invest. 97: 2705–2713, 1996.
Klip, A., T. Ramlal, D. A. Young, and J. O. Holloszy. Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 224: 224–230, 1987.
Klippel, A., C. Reinhard, M. Kavanaugh, G. Apell, M. A. Escobedo, and T. L. Williams. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transduction kinase pathways. Mol. Cell. Biol. 16: 4117–4127, 1996.
Kohn, A. D., K. S. Kovacina, and R. A. Roth. Insulin stimulates the kinase activity of RAK-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J 14: 4288–4295, 1995.
Kohn, A. D., S. A. Summers, M. J. Birnbaum, and R. A. Roth. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-Li adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271: 31372–31378, 1996.
Krook, A., Y. Kawano, X. M. Song, S. Efendic, R. A. Roth, H. Wallberg-Henriksson, and J. R. Zierath. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki (GK) rats. Diabetes 46: 2110–2114. 1997.
Leturque, A., M. Loizeau, S. Vaulont, M. Salminen, and J. Girard. Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45: 23–27, 1996.
Lund, S., G. D. Holman, O. Schmitz, and O. Pedersen. Glut 4 content in the plasma membrane of rat skeletal muscle: comparative studies of the subcellular fractionation method and the exofacial photolabelling technique using ATB-BMPA. FEBS Lett 330: 312–318, 1993.
Lund, S., G. D. Holman, O. Schmitz, and O. Pedersen. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc. Natl. Acad. Sci. USA 92: 5817–5821, 1995.
Maegawa, H., Y. Shigeta, K. Egawa, and M. Kobayashi. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 40: 815–819, 1991.
Marshall, B. A., J.-M. Ren, D. W. Johnson, E. M. Gibbs, J. S. Lillquist, W. C. Soeller, J. O. Holloszy, and M. M. Mueckler. Germline manipulation of glucose homeostasis via alterations of glucose transporter levels in skeletal muscle. J. Biol. Chem. 268: 18442–18445, 1993.
Marshall, B. A., and M. M. Mueckler. Differential effects of GLUTI or GLUT4 overexpression on insulin responsiveness in transgenic mice. Am. J. Physiol. 267: E738–744, 1994.
Mårin, P., S. Rebuffe-Service, U. Smith, and P. Björntorp. Glucose uptake in human adipose tissue. Metabolism 36: 1154–1160, 1987.
Nolte, L. A., S. M. Abdel-Halim, I. K. Martin, A. Guenifi, J. R. Zierath, C. G. Östenson, and H. Wallberg-Henriksson. Development of decreased insulin-stimulated glucose transport in skeletal muscle of glucoseintolerant hybrids of diabetic GK rats. Clin. Sci. 88: 301–306, 1995.
Östenson, C-Ö., A. Khan, S. M. Abdel-Halim, A. Guenifi, K. Suzuki, Y. Goto, and S. Efendic. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetplogia 36: 3–8, 1993.
Pedersen, O., J. F. Bak, P. H. Andersen, S. Lund, D. E. Moller, J. S. Flier, B. Kahn. Evidence against altered expression of GLUTI or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865–870, 1990.
Picarel-Blanchot, F., C. Berthelier, D. Bailbé, and B. Portha. Impaired insulin secretion and excessive hepatic glucose production are both early events in the diabetic GK rat. Am. J. Physiol. 34: E755–E762, 1996.
Ren, J.-M., B. A. Marshall, E. A. Gulve, J. Gao, D. W. Johnson, J. O. Holloszy, and M. M. Mueckler. Evidence from transgenic mice that glucose transport is rate limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol. Chem. 268: 16115–26113, 1993.
Ren, J.-M., B. A. Marshall, M. M. Mueckler, M. McCaleb, J. M. Amatruda, and G. I. Schulman. Overexpression of GLUT4 protein in muscle increases basal and insulin-stimulated whole body glucose homeostasis in conscious mice. J. Clin. Invest. 95: 429–432, 1995.
Richter, E. A., T. Ploug, and H. Galbo. Increased muscle glucose uptake after exercise. No need for insulin during exercise. Diabetes. 34: 1041–1048, 1985.
Richter, E. A., B. F. Hansen, S. A. Hansen. Glucose-induced insulin resistance of skeletal muscle glucose transport and uptake. Biochem. J. 252: 733–737, 1988.
Rossetti, L., D. Smith, G. I. Schulman, D. Papachristou, and R. A. DeFronzo. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79: 1510–1515, 1987.
Saad, M. J. A., E. Araki, M. Miralpeix, P. L. Rothenberg, M. F. White, and C. R. Kahn. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J. Clin. Invest 90: 1839–1849, 1992.
Saad, M. J. A., F. Folli, J. A. Kahn, and C. R. Kahn. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J. Clin. Invest. 92: 2065–2072, 1993.
Seals D. R., J. M. Hagberg, W. K. Allen, B. F. Hurley, G. P. Dalsky, A. A. Ehsani, and J. O. Holloszy. Glucose intolerance in young and older athletes and sedentary men. J. Appl. Physiol. 56: 1521–1525, 1984.
Stenbit, A. E., R. Burcelin, E. B. Katz, T.-S. Tsao, N. Gautier, M. J. Charron, and Y. Marchand-Brustel. Diverse effects of GLUT4 ablation on glucose uptake and glycogen synthesis in red and white muscle. J. Clin. Invest. 98: 629–634, 1996.
Tanti, J. F., S. Grillo, T. Grémeaux, P. J. Coffer, E. Van Obberghen, and Y. Le Marchand-Brustel. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 138: 2005–2010, 1997.
Trovati, M., Q. Carta, F. Cavalot, S. Vitali, C. Banaudi, S.P.G. Lucchina, F. Fiocchi, G. Emanuelli, and G. Lenti. Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care. 7: 416–420, 1984.
Tsao, T.-S., R. Burcelin, E. B. Katz, L. Huang, and M. J. Charron. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45: 28–36, 1996.
Tsao, T.-S., A. E. Stenbit, J. Li, K. L. Houseknecht, J. R. Zierath, E. B. Katz, and M. J. Charron. Musclespecific transgenic complementation of GLUT4-deficient mice. Effects on glucose but not lipid metabolism. J. Clin. Invest. 100: 671–677, 1997.
Wallberg-Henriksson, H., and J. O. Holloszy. Activation of glucose transport by muscle contraction in severely diabetic rats. Am. J. Physiol. 249. (Cell Physiol. 18) 57: C233–C237, 1985.
Wallberg-Henriksson, H., N. Zetan, and J. Henriksson. Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation: Insulin is not required. J. Biol. Chem. 262: 7665–7671, 1987.
Wallberg-Henriksson, H. Glucose transport in skeletal muscle. Influence of contractile activity, insulin, catecholamines, and diabetes mellitus. Acta Physiol. Scand. 131(Suppl. 564): 1-80.
Wilson, C. M., and S. W. Cushman. Insulin stimulation of glucose transport activity in rat skeletal muscle: increase in cell surface GLUT4 as assessed by photolabelling. Biochem. J. 299: 755–759, 1994.
Yki-Järvinen, H., E. Helve, and V. Koivisto. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 36: 892–896, 1987.
Zierath, J. R., D. Galuska, L. A. Nolte, A. Thörne, J. Smedegaard Kristensen, and H. Wallberg-Henriksson. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 37: 270–277, 1994.
Zierath, J. R., He, L., A. Gumá, E. Odegaard-Wahlström, A. Klip, and H. Wallberg-Henriksson. Insulin action on glucose transport and plasma membrane content in skeletal muscle from patients with NIDDM. Diabetologia 39: 1180–1189, 1996.
Zierath, J. R. In vitro studies of human skeletal muscle. Hormonal and metabolic regulation of glucose transport. Acta. Physiol. Scand. 155 (Suppl. 626): 1–96, 1995.
Zierath, J. R., K. Houseknecht, L. Gnudi, and B. B. Kahn. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 46: 215–223, 1997.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Galuska, D., Ryder, J., Kawano, Y., Charron, M.J., Zierath, J.R. (1998). Insulin Signaling and Glucose Transport in Insulin Resistant Skeletal Muscle. In: Richter, E.A., Kiens, B., Galbo, H., Saltin, B. (eds) Skeletal Muscle Metabolism in Exercise and Diabetes. Advances in Experimental Medicine and Biology, vol 441. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1928-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1928-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1930-4
Online ISBN: 978-1-4899-1928-1
eBook Packages: Springer Book Archive